Patent · US Active

Indazole-heteroaryl derivatives

US7884126B2 · kind B2 · utility

1Cited by

0References

3Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Markus Klein · Weiterstadt, DE
Rolf Gericke · Seeheim-Jugenheim, DE
Werner Mederski · Zwingenberg, DE
Norbert Beier · Reinheim, DE
Florian Lang · Gilching, DE

Key dates

Filing date	Jan 10, 2007
Grant date	Feb 8, 2011
Priority date	—
Expiry date	Jun 14, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D409/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to novel indazole derivatives as cited in claim 1, which are inhibitors of CHK1, CHK2 and SGK kinases and can be used to treat cancer and other diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.